Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy
February 13th 2013Granulocyte colony-stimulating factor therapy reduces hospitalizations and improves chemotherapy administration in elderly breast cancer patients, but increases overall Medicare costs during first year of therapy.